Lutein + zeaxanthin

Carotenoids. Antioxidants for vision

ATC code: S01XA-LUTEIN (Lutein and zeaxanthin (generic group) – local code)

Brand names – supplements

PreserVision AREDS 2, Ocuvite Adult 50+, Macular Health Formula

Supplements are not tested in clinical trials and are not registered as medications.

Mechanism of action

Lutein and zeaxanthin are xanthophyll carotenoids that accumulate in the macular region of the retina. They form the macular pigment, which filters blue light (400–500 nm) and neutralises reactive oxygen species in photoreceptors. They reduce oxidative stress in the macula. Not endogenously synthesised – derived only from diet or supplements. Macular concentration depends on individual diet and genetic transport factors.

Indications

Age-related macular degeneration

Adjunct

Lutein 10 mg + zeaxanthin 2 mg combination as part of the AREDS2 formula (with vitamins C, E, zinc, copper) is recommended in intermediate and late dry age-related macular degeneration in adults from age 50. AAO 2020 classifies this as a level II recommendation (moderate-quality evidence). Reduces the risk of progression to late AMD by 25% over 5 years per the AREDS2 RCT (3,036 participants). Isolated lutein without the complete AREDS2 formula has not shown efficacy.

Not indicated in patients without AMD signs – the effect in people with intact retina is not proven. In smokers, lutein replaces beta-carotene in the AREDS formula – beta-carotene increases lung cancer risk in smokers.

Sources

Cataract prevention

Not recommended

Cochrane 2012 did not confirm a clinically meaningful effect of lutein and zeaxanthin on age-related cataract prevention. Some observational studies showed a modest inverse association between dietary carotenoid intake and cataract risk – but not RCTs. Standard cataract prevention: UV protection, smoking cessation, glycaemic control in diabetes.

Sources

Cochrane: Antioxidant vitamin and mineral supplements for preventing age-related cataract (2012)

Digital eye strain (computer vision syndrome)

Not recommended

The use of lutein and zeaxanthin to reduce digital eye strain is not mentioned in international ophthalmology guidelines. The marketing position of “blue light protection from screens” relies on the physiological mechanism of blue light filtering by the macular pigment, but a clinical effect on eye strain symptoms, productivity, or sleep has not been confirmed in large RCTs. Foundational approaches: 20-20-20 rule, ergonomic optimisation, lubricating drops.

Sources

AAO: Age-Related Macular Degeneration Preferred Practice Pattern (2020)

Practical notes

Timing and administration

Take with food, preferably one containing fat – lutein and zeaxanthin are fat-soluble and absorption increases 3-fold with fat. Effect on macular accumulation develops over 3–6 months.

Dose titration

Dose in the AREDS2 RCT: lutein 10 mg + zeaxanthin 2 mg daily. This combination is in PreserVision AREDS 2 and Ocuvite Lutein Forte. Isolated lutein without the complete AREDS2 formula (vitamin C 500 mg, E 400 IU, zinc 80 mg, copper 2 mg) is less effective.

Monitoring

No specific laboratory monitoring is required. In AMD patients, regular ophthalmology examinations with visual acuity testing, optical coherence tomography (OCT) of the macula, and Amsler grid testing every 6–12 months depending on stage. The supplement effect is to slow progression, not improve vision.

Food and drinks

Dietary sources of lutein and zeaxanthin: dark leafy greens (spinach, kale, parsley – 12 mg lutein per 100 g), egg yolk, sweet corn, orange pepper, broccoli. Egg yolk lutein bioavailability is higher than from plant sources due to accompanying fats. Regular consumption of 1–2 servings of dark greens daily provides 10–20 mg lutein.

Common myths

Myth: “lutein is needed for everyone at a computer to protect the eyes”. Fact: an effect on digital eye strain is not confirmed in RCTs. In people without AMD, prophylactic use has no proven benefit.

Myth: “lutein restores vision”. Fact: the effect is slowing AMD progression, not improving acuity. In patients without retinal pathology, there is no effect on vision.

Myth: “isolated lutein is effective”. Fact: AREDS2 showed an effect only as part of the complete formula (lutein + zeaxanthin + vitamins C, E + zinc + copper). Isolated lutein without accompanying components has not confirmed clinical benefit in AMD.

Safety

Contraindications

Hypersensitivity to components
Pregnancy and breastfeeding (insufficient data)

Serious adverse effects

Serious adverse effects at standard doses are not reported

Common adverse effects

Side effects at standard doses are rare

Uncommon adverse effects

Mild yellowish skin discoloration with long-term high-dose use (carotenodermia, reversible)
Epigastric discomfort

PregnancyFDA C

Pregnancy data are insufficient. Lutein and zeaxanthin from dietary sources are safe. Supplement use in pregnancy is not recommended without clinical indication.

Breastfeeding

Transfers into breast milk. The effect of maternal supplementation on the infant has not been studied.